Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0299267 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Lujia Wang und 24 weiteren Autor:innen. Beteiligte Einrichtung: H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States of America. Hauptthemen laut MEDLINE: Glioblastoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Directorate for Mathematical and Physical Sciences, National Institutes of Health.
Abstract (Originalsprache)
Background and objective Glioblastoma (GBM) is one of the most aggressive and lethal human cancers. Intra-tumoral genetic heterogeneity poses a significant challenge for treatment. Biopsy is invasive, which motivates the development of non-invasive, MRI-based machine learning (ML) models to quantify intra-tumoral genetic heterogeneity for each patient. This capability holds great promise for enabling better therapeutic selection to improve patient outcome.
Methods
We proposed a novel Weakly Supervised Ordinal Support Vector Machine (WSO-SVM) to predict regional genetic alteration status within each GBM tumor using MRI. WSO-SVM was applied to a unique dataset of 318 image-localized biopsies with spatially matched multiparametric MRI from 74 GBM patients. The model was trained to predict the regional genetic alteration of three GBM driver genes (EGFR, PDGFRA and PTEN) based on features extracted from the corresponding region of five MRI contrast images. For comparison, a variety of existing ML algorithms were also applied. Classification accuracy of each gene were compared between the different algorithms. The SHapley Additive exPlanations (SHAP) method was further applied to compute contribution scores of different contrast images. Finally, the trained WSO-SVM was used to generate prediction maps within the tumoral area of each patient to help visualize the intra-tumoral genetic heterogeneity.
Results
WSO-SVM achieved 0.80 accuracy, 0.79 sensitivity, and 0.81 specificity for classifying EGFR; 0.71 accuracy, 0.70 sensitivity, and 0.72 specificity for classifying PDGFRA; 0.80 accuracy, 0.78 sensitivity, and 0.83 specificity for classifying PTEN; these results significantly outperformed the existing ML algorithms. Using SHAP, we found that the relative contributions of the five contrast images differ between genes, which are consistent with findings in the literature. The prediction maps revealed extensive intra-tumoral region-to-region heterogeneity within each individual tumor in terms of the alteration status of the three genes.
Conclusions
This study demonstrated the feasibility of using MRI and WSO-SVM to enable non-invasive prediction of intra-tumoral regional genetic alteration for each GBM patient, which can inform future adaptive therapies for individualized oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States of America.
- Institute for Cancer Genetics, Columbia University Medical Center, New York City, New York, United States of America.
- Department of Neurosurgery, Mayo Clinic Arizona, Phoenix, Arizona, United States of America.
- Department of Neurosurgery, Barrow Neurological Institute-St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States of America.
- Department of Pathology, Mayo Clinic Arizona, Phoenix, Arizona, United States of America.
- Department of Neuropsychology, Mayo Clinic Arizona, Phoenix, Arizona, United States of America.
ORCID-Profile: Fulvio D'Angelo, Kyle W Singleton, Peter Nakaji, Kliment Donev, Jing Li
Förderung
- NCI NIH HHS
- Directorate for Mathematical and Physical Sciences
- National Institutes of Health
Zitieren
APA
Wang, L., Wang, H., D'Angelo, F., Curtin, L., Sereduk, C. P., Leon, G., Singleton, K. W., Urcuyo, J., Hawkins-Daarud, A., Jackson, P. R., Krishna, C., Zimmerman, R. S., Patra, D. P., Bendok, B. R., Smith, K. A., Nakaji, P., Donev, K., Baxter, L. C., Mrugała, M. M., …, & Li, J. (2024). Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm. PLOS ONE. https://doi.org/10.1371/journal.pone.0299267
Vancouver
Wang L, Wang H, D'Angelo F, Curtin L, Sereduk CP, Leon G, et al. Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm. PLOS ONE. 2024. doi:10.1371/journal.pone.0299267
BibTeX
@article{Wang2024,
author = {Wang, Lujia and Wang, Hairong and D'Angelo, Fulvio and Curtin, Lee and Sereduk, Christopher P and Leon, Gustavo De and Singleton, Kyle W and Urcuyo, Javier and Hawkins-Daarud, Andrea and Jackson, Pamela R and Krishna, Chandan and Zimmerman, Richard S and Patra, Devi P and Bendok, Bernard R and Smith, Kris A and Nakaji, Peter and Donev, Kliment and Baxter, Leslie C and Mrugała, Maciej M and Ceccarelli, Michele and Iavarone, Antonio and Swanson, Kristin R and Tran, Nhan L and Hu, Leland S and Li, Jing},
title = {Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0299267}
}
EUVIMED